Danaher Corp., US2358511028

Danaher partners with NVIDIA as Danaher Corporation stock trades at EUR 206.90

Published on 10/16/2026 at 10:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher Corporation stock trades at EUR 206.90 on October 16, 2026. Second-quarter revenue reached USD 6.26 billion.

AI collaboration and upcoming results

  • Danaher announced its NVIDIA collaboration on October 14, 2026, combining laboratory systems with accelerated computing.
  • Second-quarter 2026 revenue reached USD 6.26 billion, up 5.50 percent year over year.
  • Danaher Corporation stock traded at EUR 206.90 at 10:06 a.m. CEST at Lang & Schwarz on October 16, 2026.
  • Danaher scheduled its third-quarter 2026 earnings call for October 21, 2026.
Danaher Corp. DNA-Doppelhelix US2358511028 in leuchtendem Blau als extreme Makroaufnahme molekularer Struktur, Illustration mit AI erstellt.

Danaher Corporation (ISIN US2358511028) was trading at EUR 206.90 at Lang & Schwarz on October 16, 2026, as the healthcare technology group advanced an artificial-intelligence collaboration with NVIDIA. The companies announced the partnership on October 14, 2026, according to Danaher.

AI partnership targets laboratory workflows

The collaboration combines Danaher's scientific instruments, automation technologies and laboratory workflow software with NVIDIA accelerated computing and AI tools. Initial work includes DGX Spark, RAPIDS and BioNeMo Open Models, while the companies are exploring broader applications for scientific instruments and digital laboratory workflows, Yahoo Finance reported on October 14, 2026.

The commercial terms were not disclosed, so the immediate investor test is execution rather than near-term revenue. Danaher said the project aims to connect predictions, experiments and laboratory data in a continuous learning cycle.

Three dates show the strategy

On July 20, 2026, Danaher reported second-quarter revenue of USD 6.26 billion, up 5.50 percent from the prior-year period, while adjusted earnings per share reached USD 1.94 against a USD 1.85 consensus estimate, according to MarketBeat. On October 7, 2026, Danaher announced an autonomous laboratory project expected to deliver up to 8 times faster discovery of affinity reagents, according to The Pharma Vanguard. The October 14 NVIDIA collaboration added three named technology components to that strategy.

What dates matter next?

Danaher scheduled its third-quarter 2026 earnings conference call for October 21, 2026, beginning at 8:00 a.m. ET, according to the company's press-release calendar. The next report will show whether the second-quarter revenue increase and the AI initiatives are translating into operating progress.

Stock trades at EUR 206.90

Danaher had a market capitalization of USD 162.7 billion as of October 15, 2026, while its 52-week range was USD 160.93 to USD 242.80. Its primary listing is on the NYSE, where the stock was last quoted at USD 231.50 after the October 15 session.

Danaher stock was trading at EUR 206.90 at Lang & Schwarz on October 16, 2026 at 10:06 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Danaher Corp stock.

Danaher Corporation stock facts

  • Company: Danaher Corporation
  • ISIN: US2358511028
  • Ticker: DHR
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 16, 2026, 10:06 a.m. CEST): EUR 206.90
  • Market capitalization: USD 162.7 billion (as of October 15, 2026)
  • 52-week range: USD 160.93-242.80 (as of October 15, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research

Market context: Market report S&P 500.

More news and analyses on Danaher Corp stock

Disclaimer...
en | US2358511028 | DANAHER CORP. | boerse | 70337974 | bgmi